| scholarly article | Q13442814 |
| P2093 | author name string | Amandeep Bajwa | |
| Canan Kuscu | |||
| Valeria Mas | |||
| Daniel Maluf | |||
| Cem Kuscu | |||
| LiPing Huang | |||
| Liza Makowski | |||
| Maria Namwanje | |||
| James D Eason | |||
| Kailo Schlegel | |||
| Thomas V Rousselle | |||
| P2860 | cites work | Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation | Q24629370 |
| Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation | Q24682128 | ||
| Regulatory myeloid cells in transplantation | Q26999875 | ||
| Regulatory dendritic cell therapy: from rodents to clinical application | Q27025996 | ||
| Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs | Q27322277 | ||
| Sphingosine 1-phosphate induces chemotaxis of immature and modulates cytokine-release in mature human dendritic cells for emergence of Th2 immune responses | Q28210836 | ||
| A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis | Q28270998 | ||
| Expression of the sphingosine 1-phosphate receptor, S1P1, on T-cells controls thymic emigration | Q28592508 | ||
| Immunobiology of dendritic cells | Q29547465 | ||
| An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow | Q29615498 | ||
| Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists | Q29618071 | ||
| Endothelial Sphingosine 1‑Phosphate Receptor‑1 Mediates Protection and Recovery from Acute Kidney Injury | Q30275541 | ||
| Sphingosine 1-Phosphate Receptor 3-Deficient Dendritic Cells Modulate Splenic Responses to Ischemia-Reperfusion Injury | Q30278837 | ||
| Sphingosine 1-phosphate receptor-1 enhances mitochondrial function and reduces cisplatin-induced tubule injury. | Q30359883 | ||
| Dendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injury | Q30423015 | ||
| Dendritic cell sphingosine 1-phosphate receptor-3 regulates Th1-Th2 polarity in kidney ischemia-reperfusion injury | Q30423883 | ||
| Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation | Q30431948 | ||
| Activation of sphingosine-1-phosphate 1 receptor in the proximal tubule protects against ischemia-reperfusion injury | Q30432124 | ||
| Macrophages, dendritic cells, and kidney ischemia-reperfusion injury | Q30432565 | ||
| Immune mechanisms and novel pharmacological therapies of acute kidney injury | Q30434767 | ||
| Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury | Q30435312 | ||
| IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury | Q30437432 | ||
| Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury | Q30439331 | ||
| The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury | Q30439547 | ||
| Sphingosine-1-phosphate receptors: biology and therapeutic potential in kidney disease | Q30440476 | ||
| NKT cell activation mediates neutrophil IFN-gamma production and renal ischemia-reperfusion injury | Q30443445 | ||
| Functions of a new family of sphingosine-1-phosphate receptors | Q31640177 | ||
| CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. | Q33246091 | ||
| Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor | Q33266079 | ||
| Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages | Q34071063 | ||
| Sphingosine 1-phosphate, a key cell signaling molecule | Q34128454 | ||
| Assessing mitochondrial dysfunction in cells. | Q34793639 | ||
| PCR based determination of mitochondrial DNA copy number in multiple species | Q35034159 | ||
| TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation | Q35173133 | ||
| Cellular pathophysiology of ischemic acute kidney injury | Q35484725 | ||
| Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in mice | Q35698980 | ||
| Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury | Q35715879 | ||
| Topographical and biological evidence revealed FTY720-mediated anergy-polarization of mouse bone marrow-derived dendritic cells in vitro | Q36000945 | ||
| Identification of the CD4(+) T cell as a major pathogenic factor in ischemic acute renal failure | Q36169286 | ||
| Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. | Q36177914 | ||
| Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network | Q36184401 | ||
| Rapid isolation and purification of mitochondria for transplantation by tissue dissociation and differential filtration | Q36788091 | ||
| Ischemia-reperfusion and immediate T cell responses | Q36973884 | ||
| Disease-modifying agents for multiple sclerosis: recent advances and future prospects | Q37328280 | ||
| Development of dendritic cell-based immunotherapy for autoimmunity | Q37701864 | ||
| Moving to tolerance: clinical application of T regulatory cells | Q37881151 | ||
| Emerging role of innate immunity in organ transplantation: part I: evolution of innate immunity and oxidative allograft injury | Q37945971 | ||
| Dendritic cell vaccination in autoimmune disease | Q38078202 | ||
| Local application of FTY720 to the lung abrogates experimental asthma by altering dendritic cell function | Q38904716 | ||
| Renal ischemia-reperfusion injury: renal dendritic cells loudly sound the alarm. | Q53563325 | ||
| Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. | Q53874628 | ||
| Analysis of mtDNA/nDNA Ratio in Mice. | Q54878977 | ||
| Biodistribution and vaccine efficiency of murine dendritic cells are dependent on the route of administration | Q57779785 | ||
| Mesenchymal stem cells and their mitochondrial transfer: a double-edged sword. | Q64972643 | ||
| FTY720 application following isolated warm liver ischemia improves long-term survival and organ protection in a mouse model | Q79959742 | ||
| Signals from type 1 sphingosine 1-phosphate receptors enhance adult mouse cardiac myocyte survival during hypoxia | Q80980910 | ||
| FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia in C57/BL6 mice | Q83220017 | ||
| Dendritic Cells As Inducers of Peripheral Tolerance | Q88820708 | ||
| Tacrolimus in combination with FTY720--an analysis of renal and blood parameters | Q95814552 | ||
| Sphingosine kinase 1 protects against renal ischemia-reperfusion injury in mice by sphingosine-1-phosphate1 receptor activation | Q39488891 | ||
| The immune modulator FTY720 targets sphingosine 1-phosphate receptors | Q40736684 | ||
| Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation | Q40763807 | ||
| Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury | Q42128038 | ||
| Mouse lines with photo-activatable mitochondria to study mitochondrial dynamics | Q42257935 | ||
| Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation | Q42320254 | ||
| Adoptive transfer of FTY720-treated immature BMDCs significantly prolonged cardiac allograft survival | Q43034429 | ||
| FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model | Q43552670 | ||
| First human trial of FTY720, a novel immunomodulator, in stable renal transplant patients | Q43931513 | ||
| Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720. | Q44002416 | ||
| FTY720: a novel approach to the treatment of hepatic ischemia-reperfusion injury | Q44101254 | ||
| FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration | Q44188438 | ||
| Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice | Q44260906 | ||
| FTY720 for treatment of ischemia-reperfusion injury following complete renal ischemia; impact on long-term survival and T-lymphocyte tissue infiltration | Q44299688 | ||
| Immunosuppression with FTY720 and cyclosporine A inhibits rejection of adult porcine islet xenografts in rats | Q44419307 | ||
| FTY720 reduces T-cell recruitment into murine intestinal allograft and prevents activation of graft-infiltrating cells | Q44469232 | ||
| The effect of immunomodulators on prevention of autoimmune diabetes is stage dependent: FTY720 prevents diabetes at three different stages in the diabetes-resistant biobreeding rat. | Q44813941 | ||
| Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney | Q44916450 | ||
| FTY720 impairs necrosis development after ischemia-reperfusion injury | Q44934183 | ||
| Design of clinical trials in acute kidney injury: a report from an NIDDK workshop--prevention trials | Q44974183 | ||
| Dynamin-Related Protein 1 Deficiency Promotes Recovery from AKI. | Q45071365 | ||
| FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers. | Q45214556 | ||
| The immunomodulator FTY720 interferes with effector functions of human monocyte-derived dendritic cells. | Q45229482 | ||
| FTY720 prevents renal T-cell infiltration after ischemia/reperfusion injury | Q46420521 | ||
| Transient FTY720 treatment promotes immune-mediated clearance of a chronic viral infection. | Q46428828 | ||
| Prevention and cure of autoimmune diabetes in nonobese diabetic mice by continuous administration of FTY720. | Q46478164 | ||
| The sphingosine-1-phosphate receptor agonist FTY720 modulates dendritic cell trafficking in vivo | Q46741854 | ||
| Vitamin D3 Induces Tolerance in Human Dendritic Cells by Activation of Intracellular Metabolic Pathways | Q49160110 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 1278 | |
| P577 | publication date | 2020-06-23 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | FTY720 Regulates Mitochondria Biogenesis in Dendritic Cells to Prevent Kidney Ischemic Reperfusion Injury | |
| P478 | volume | 11 |
Search more.